CD9 antigen

Subscribe to Selected New Research on CD9 antigen

30 relevant articles (1 outcomes, 1 trials/studies) found for this Bio-Agent

Description: a tetraspanin family member required for sperm-egg fusion, putative INTERLEUKIN-16 receptor

Also Known As:

27 kDa diphtheria toxin receptor-associated protein; CD9 antigen (p24) protein, human; CD9 antigen, human; CD9 antigen, mouse; CD9 antigens; CD9 protein, human; Cd9 protein, mouse; DRAP27 protein; TSPAN29 protein, human; Tspan29 protein, mouse; antigens, CD9; human leukemia-associated antigen p24; leukemia-associated cell surface antigen p24; motility-related protein-1; p24-CD9 antigen; tetraspanin-29

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins

Proteins: 56522

Glycoproteins: 15216

Membrane Glycoproteins: 1731

CD9 antigen: 30

Membrane Proteins: 4214

Membrane Glycoproteins: 1731

CD9 antigen: 30

Biological Factors: 868

Antigens: 93142

Surface Antigens: 3823

Differentiation Antigens: 865

CD Antigens: 29

CD9 antigen: 30

Biological Markers: 18489

Differentiation Antigens: 865

CD Antigens: 29

CD9 antigen: 30

Experts

1.	Li, Jia-wen: 1 article (07/2007)
2.	Lin, Yun: 1 article (07/2007)
3.	Zhang, Xiao-bing: 1 article (07/2007)
4.	Liu, Hou-jun: 1 article (07/2007)
5.	Wu, Yan: 1 article (07/2007)
6.	Zheng, Li-duan: 1 article (07/2007)
7.	Van Camp, B: 1 article (10/2006)
8.	Caers, J: 1 article (10/2006)
9.	De Raeve, H: 1 article (10/2006)
10.	Andersen, T L: 1 article (10/2006)

Related Diseases

1.	Aseptic Meningitis 07/01/1990 - "However, CD9 antigen was not released into CSF from 11 cases of CD9- ALL with CNS involvement, 136 cases of CD9+ ALL in complete remission (CR), 29 cases of CD9- ALL in CR, or 21 cases of aseptic meningitis" Get all the results and reference details, order at left...
2.	Melanoma (Melanoma, Malignant) 07/01/2007 - "OBJECTIVE: To study the expression of neutral endopeptidase (CD10) and motility-related protein-1 (CD9) in malignant melanoma and their clinical significance" 07/01/2007 - "Expression of neutral endopeptidase and motility-related protein-1 in cutaneous malignant melanoma]" 01/05/1991 - "Sequence and structural comparisons showed extensive similarity of the CD9 antigen with a 237-amino acid molecule described previously as the human melanoma-associated antigen ME491 and a Schistosoma mansoni membrane protein of 218 amino acids" Get all the results and reference details, order at left...
3.	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/01/1994 - "Shedding of CD9 antigen in acute lymphoblastic leukemia." 09/01/1993 - "The CD9 antigen was originally described as a 24 kDa molecule present on B lineage-derived acute lymphoblastic leukemia cells and developing B-lymphocytes" 04/01/1993 - "The CD9 antigen was originally described as a 24-kDa molecule present on B-lineage-derived acute lymphoblastic leukemia cells and developing B lymphocytes" 01/05/1991 - "The CD9 antigen was described originally as a 24-kDa surface protein of non-T acute lymphoblastic leukemia cells and developing B-lymphocytes" 07/01/1990 - "Shedding of CD9 antigen into cerebrospinal fluid by acute lymphoblastic leukemia cells." Get all the results and reference details, order at left...
4.	Neoplasms (Cancer) 01/01/2005 - "CD9, a transmembrane protein known as motility-related protein-1, plays a pivotal role in regulating cell adhesion, motility, and proliferation, and has been regarded as an important metastasis-inhibitory factor of various human cancers" 03/01/1999 - "Although the mechanisms of action of the transmembrane superfamilies, motility-related protein-1 (MRP-1/CD9) and KAI1/CD82, are not well known, they are reported to suppress the metastasis of several kinds of cancers" 12/01/2004 - "Many genes whose increased expression was thought to be related to tumor progression were identified, such as c-Met, ezrin, integrin, motility-related protein-1, cadherin, and S100A4" 04/22/1997 - "Motility-related protein-1 (MRP-1)/CD9 is a trans-membrane glycoprotein closely associated with suppression of cell motility and reduced metastatic potential of some tumor cells" Get all the results and reference details, order at left...
5.	Neoplasm Metastasis (Metastasis) 02/01/2002 - "In addition, we have also cloned the motility-related protein-1 (MRP-1)/cluster of differentiation 9 (CD9) as a metastasis suppressor molecule" 11/02/2000 - "Suppression of pulmonary metastasis using adenovirally motility related protein-1 (MRP-1/CD9) gene delivery." 01/01/2005 - "CD9, a transmembrane protein known as motility-related protein-1, plays a pivotal role in regulating cell adhesion, motility, and proliferation, and has been regarded as an important metastasis-inhibitory factor of various human cancers" 03/01/1999 - "Although the mechanisms of action of the transmembrane superfamilies, motility-related protein-1 (MRP-1/CD9) and KAI1/CD82, are not well known, they are reported to suppress the metastasis of several kinds of cancers" Get all the results and reference details, order at left...
22 Diseases and 30 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Neprilysin (Neutral Endopeptidase)
2.	Monoclonal Antibodies
3.	A-factor (Streptomyces)
4.	Interleukin-2 Receptor alpha Subunit
5.	Focal Adhesion Protein-Tyrosine Kinases
6.	Integrin alpha5beta1
7.	Cyclin D1
8.	CD29 Antigens
9.	Myelin-Associated Glycoprotein (S-MAG)
10.	CD1 Antigens
31 Drugs and Important Bio-Agents and 17 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Aftercare (After-Treatment)
1 Therapies and Procedures and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>